In order to define the clinical potential of selected proteins to differentiate between ERA patients and healthy controls, ROC curves were calculated with A-SAA variants, alarmins, and C-reactive protein (CRP) intensities. This evidence concerns the gene SAA2 and enthesitis-related juvenile idiopathic arthritis.